电话:025-68136891, 17366374446  

登录  |  注册
中文  English
当前位置:首页 » 教育培训 » 导师介绍 » 蒋奎荣
教育培训
蒋奎荣


蒋奎荣,主任医师、教授、博士生导师。目前担任中华医学会外科学分会手术学组委员、中华医学会外科学分会青年委员、中国医师协会肿瘤外科医师委员会委员、美国外科学院院士(FACS)、国际外科学院会员(FICS),江苏省医学会外科学分会胰腺外科学组副组长、江苏省医学会外科学分会委员、江苏省医师协会外科学分会委员、江苏医学会胰腺病分会委员兼秘书、江苏省胰腺病学会主任委员、中国研究型医院普外科专业委员会委员、中国研究型医院肝胆胰ERAS专业委员会委员、中国抗癌协会胰腺癌专业委员会微创诊疗学组委员。

现为江苏省"六大人才高峰"高层次人才培养对象,江苏省“333”工程培养对象,江苏省高校"青蓝工程"中青年学术带头人,南京医科大学“优秀中青年教师支持计划”优秀中青年学术带头人。

作为主要参与者参与“胰腺癌关键诊疗技术的创新与应用”项目,获2015年江苏省科学技术奖一等奖(排名第三);“胰腺癌基础及临床新技术研究”获2015年江苏省医学科技奖一等奖(排名第三);“胰腺癌发生发展机制与临床技术创新研究”获2015年中华医学科技进步奖二等奖(排名第三);“中段胰腺切除术”获2013年江苏省卫生厅医学新技术引进一等奖(排名第二);“胰腺癌基础及临床研究”获2012年教育部科技进步二等奖(排名第三)。



所获人才项目及科研课题

2013.1-2016.12国家自然科学基金,胰腺星状细胞高表达Galectin-1通过SDF-1/CXCR4轴诱导胰腺癌肝转移的机制研究,负责人

2010.1-2012.12 国家自然科学基金,胰腺星状细胞高表达Galectin-1促进胰腺癌免疫抑制的机制研究,负责人

2013.1-2017.1 卫生部行业基金,胰腺癌早期诊断与综合治疗的转化医学研究子课题,主要参加者

2009.1-2013.1 科技部“十一五”支撑计划,《胰腺癌综合治疗体系研究》子课题,主要参加者

2014.11-2018.12 江苏省”六大人才高峰”高层次人才培养对象(B类项目),缺氧微环境中胰腺星状细胞和胰腺癌细胞高表达HIF-1α调控肿瘤侵袭转移机制研究,负责人


主要学术论著

1.    WuJ, Guo F, Wei J, et al. [Surgical treatment for pancreatic neuroendocrineneoplasmas]. Zhejiang da xue xue bao Yi xue ban = Journal of Zhejiang UniversityMedical sciences 2016; 45(1): 31-5.

2.    WeiJ, Liu X, Wu J, et al. Diagnosis and surgical management of insulinomas in 33consecutive patients at a single institution. Langenbeck's archives of surgery2016; 401(7): 1019-25.

3.    TuM, Lu C, Lv N, et al. Vasohibin 2 promotes human luminal breast cancerangiogenesis in a non-paracrine manner via transcriptional activation offibroblast growth factor 2. Cancer letters 2016; 383(2): 272-81.

4.    QianD, Lu Z, Jackson R, et al. Effect of antecolic or retrocolic route ofgastroenteric anastomosis on delayed gastric emptying afterpancreaticoduodenectomy: A meta-analysis of randomized controlled trials.Pancreatology : official journal of the International Association ofPancreatology (IAP)  [et al] 2016; 16(1):142-50.

5.    LuZ, Yin J, Wei J, et al. Small amounts of tissue preserve pancreatic function:Long-term follow-up study of middle-segment preserving pancreatectomy. Medicine2016; 95(46): e5274.

6.    HuoX, Wei J, Liu X, et al. Brunner's gland cyst in combination withgastrointestinal stromal tumor: A case report. Oncology letters 2016; 11(5):3409-12.

7.    GaoW, Dai X, Dai C, et al. Comparison of patency rates and clinical impact ofdifferent reconstruction methods following portal/superior mesenteric vein resectionduring pancreatectomy. Pancreatology : official journal of the InternationalAssociation of Pancreatology (IAP)  [etal] 2016; 16(6): 1113-23.

8.    ZouC, Lu Z, Zhang Z, et al. Factors associated with pancreatic infection inpatients with severe acute pancreatisis. International journal of clinical andexperimental medicine 2015; 8(8): 14100-4.

9.    WuQ, Zhang M, Qin Y, et al. Systematic review and meta-analysis of isletautotransplantation after total pancreatectomy in chronic pancreatitispatients. Endocrine journal 2015; 62(3): 227-34.

10.  WeiJ, Liu X, Wu J, et al. Modified One-layer Duct-to-mucosa PancreaticojejunostomyReduces Pancreatic Fistula After Pancreaticoduodenectomy. International surgery2015.

11.  WeiJ, Lin S, Wang C, et al. Glucagonoma syndrome: A case report. Oncology letters2015; 10(2): 1113-6.

12.  TangD, Gao J, Wang S, et al. Apoptosis and anergy of T cell induced by pancreaticstellate cells-derived galectin-1 in pancreatic cancer. Tumour biology : thejournal of the International Society for Oncodevelopmental Biology and Medicine2015; 36(7): 5617-26.

13.  GeQ, Zhou J, Tu M, et al. Nuclear vasohibin-2 promotes cell proliferation byinducing G0/G1 to S phase progression. Oncology reports 2015; 34(3): 1327-36.

14.  TuM, Liu X, Han B, et al. Vasohibin2 promotes proliferation in human breastcancer cells via upregulation of fibroblast growth factor2 andgrowth/differentiation factor15 expression. Molecular medicine reports 2014;10(2): 663-9.

15.  TangD, Zhang J, Yuan Z, et al. Pancreatic satellite cells derived galectin-1increase the progression and less survival of pancreatic ductal adenocarcinoma.PloS one 2014; 9(3): e90476.

16.  TangD, Wang D, Yuan Z, et al. Persistent activation of pancreatic stellate cellscreates a microenvironment favorable for the malignant behavior of pancreaticductal adenocarcinoma. International journal of cancer 2013; 132(5): 993-1003.

17.  SunJ, Tu M, Han B, et al. Generation and characterization of rabbit polyclonalantibodies against Vasohibin-2 for determination of its intracellularlocalization. International journal of oncology 2013; 43(1): 255-61.

18.  ChenJ, Li Q, An Y, et al. CEACAM6 induces epithelial-mesenchymal transition andmediates invasion and metastasis in pancreatic cancer. International journal ofoncology 2013; 43(3): 877-85.

19.  CaiB, An Y, Lv N, et al. miRNA-181b increases the sensitivity of pancreatic ductaladenocarcinoma cells to gemcitabine in vitro and in nude mice by targetingBCL-2. Oncology reports 2013; 29(5): 1769-76.

20.  AnY, Cai B, Chen J, et al. MAP3K10 promotes the proliferation and decreases thesensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 andGli-2. Cancer letters 2013; 329(2): 228-35.

21.  TangD, Yuan Z, Xue X, et al. High expression of Galectin-1 in pancreatic stellatecells plays a role in the development and maintenance of an immunosuppressivemicroenvironment in pancreatic cancer. International journal of cancer 2012;130(10): 2337-48.

22.  XueX, Lu Z, Tang D, et al. Galectin-1 secreted by activated stellate cells inpancreatic ductal adenocarcinoma stroma promotes proliferation and invasion ofpancreatic cancer cells: an in vitro study on the microenvironment ofpancreatic ductal adenocarcinoma. Pancreas 2011; 40(6): 832-9.